Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse
March 9th, 2022
13.7K views
The protocol describes a straightforward method of resectioning an intact mouse liver for metabolic studies through portal vein perfusion.
Overview
This video demonstrates a streamlined procedure developed to perform metabolic liver studies with sufficient rigor and reproducibility. The technique is best applied to real-time metabolism to detect the function in turnover metabolites in disease models.
Key Study Components
Area of Science
- Metabolic studies
- Liver perfusion techniques
- Disease modeling
Background
- Perfusion allows precise control of nutrients and hormones available to the liver.
- This method can be instrumental in understanding the etiology and impact of diseases.
- Applicable to models of several diseases, including diabetes, NAFLD, and NASH.
- Essential for assessing hepatic central energy metabolism as new pharmaceuticals are developed.
Purpose of Study
- To provide a guide for hepatic resection for in vivo perfusion studies.
- To enhance understanding of liver metabolism in various disease models.
- To improve the rigor and reproducibility of metabolic liver studies.
Methods Used
- Resectioning of an intact mouse liver.
- Portal vein perfusion technique.
- Real-time monitoring of liver metabolism.
- Application in various disease models.
Main Results
- Demonstrated the effectiveness of the perfusion technique.
- Showed the ability to detect metabolic functions in disease models.
- Highlighted the importance of nutrient and hormone control.
- Provided a reproducible method for future studies.
Conclusions
- The method is valuable for understanding hepatic metabolism.
- Can be applied to various stages of disease progression.
- Supports the development of new pharmaceuticals targeting liver metabolism.
Frequently Asked Questions
What is the main focus of this study?
The study focuses on a method for performing metabolic liver studies through portal vein perfusion.
How does portal vein perfusion benefit liver studies?
It allows precise control of nutrients and hormones, enhancing the study of liver metabolism.
What diseases can this method be applied to?
The method can be applied to models of diabetes, NAFLD, NASH, and cancers.
Is this technique intended for therapeutic purposes?
No, it is primarily for research to understand liver metabolism in disease contexts.
What are the key components of the method?
Key components include hepatic resection, portal vein perfusion, and real-time metabolism monitoring.
Why is reproducibility important in metabolic studies?
Reproducibility ensures that results are reliable and can be validated across different studies.
Executive Industry Relevance
Ex vivo hepatic perfusion through the portal vein in mouse provides a rigorously controlled platform for interrogating liver metabolism under defined nutritional and hormonal conditions. This approach enables high-fidelity metabolic flux analysis, supporting predictive confidence in disease-relevant models such as diabetes, NAFLD, and NASH. The method's reproducibility and compatibility with real-time NMR analytics position it as a critical asset for early discovery and mechanistic de-risking in metabolic disease portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise interrogation of hepatic metabolic pathways under controlled perturbations.
- Supports functional validation of metabolic targets in disease-relevant mouse models.
- Facilitates mechanistic de-risking by quantifying metabolic fluxes in response to disease or intervention.
- Provides a reproducible system for hypothesis-driven target evaluation.
Screening & Assay Development
- Establishes a validated ex vivo platform for quantitative metabolic readouts.
- Standardizes nutrient and hormone delivery to ensure assay reproducibility.
- Enables real-time monitoring of metabolic turnover for compound evaluation.
- Supports scalability and platform reuse across metabolic disease studies.
Translational & Preclinical Research
- Aligns metabolic flux measurements with disease progression and biomarker development.
- Provides translational continuity from discovery through preclinical validation in metabolic disease models.
- Enables risk-adjusted advancement decisions based on quantitative metabolic endpoints.
- Supports mechanistic insights into pharmaceutical intervention effects on hepatic metabolism.
Pipeline & Workflow Integration
This ex vivo perfusion method integrates into the discovery-to-preclinical continuum for metabolic disease research, bridging hypothesis testing, target validation, and translational analytics.
- Discovery Biology: Supports rigorous hypothesis testing and pathway clarification in hepatic metabolism.
- Screening: Delivers reproducible, quantitative metabolic outputs for compound assessment.
- Analytics: Enables real-time NMR-based measurement of metabolic fluxes and oxygen consumption.
- Translational Research: Connects metabolic readouts to disease progression and biomarker strategies.
- Enterprise Reuse: Functions as a reusable platform for diverse metabolic disease and intervention studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in metabolic target validation.
- Operational Value: Delivers standardized, reproducible, and scalable ex vivo workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust metabolic endpoint analysis.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of metabolic disease programs.
Implementation Considerations
- Requires expertise in microsurgical techniques and ex vivo perfusion setup.
- Demands access to NMR or MRI infrastructure for real-time metabolic analysis.
- Necessitates rigorous cross-team standardization to ensure reproducibility.
- Adaptable to various disease models and stages with protocol refinements.
- Dependent on high-quality surgical execution to maintain tissue viability and data integrity.
Biopharma FAQs
Why does null hypothesis testing matter for ex vivo liver perfusion?
Null hypothesis testing in ex vivo liver perfusion enables objective evaluation of metabolic changes under controlled conditions, supporting robust target validation. This statistical rigor ensures that observed effects are attributable to specific interventions or disease states, reducing false positives in early discovery. Reliable hypothesis testing underpins confidence in advancing metabolic targets within the portfolio.
How does independent variable isolation fit the hepatic perfusion workflow?
Isolating independent variables such as nutrient or hormone levels during perfusion allows precise attribution of metabolic responses to specific perturbations. This control is essential for dissecting pathway mechanisms and evaluating pharmaceutical effects in disease models. Such isolation strengthens mechanistic de-risking and informs downstream screening strategies.
What do quantitative dependent variable measurements enable in NMR-based perfusion studies?
Quantitative measurements of metabolic fluxes and oxygen consumption via NMR provide actionable endpoints for comparing disease states and intervention effects. These outputs enable teams to benchmark compound efficacy and metabolic impact with high reproducibility. Quantitative data support data-driven advancement decisions in metabolic disease research.
Why are replication requirements critical for cross-functional metabolic studies?
Replication ensures that metabolic findings from ex vivo perfusion are robust and transferable across teams and studies. High reproducibility facilitates cross-functional collaboration, enabling consistent assay performance and data comparability. Meeting replication standards is vital for enterprise-wide confidence in metabolic target evaluation.
What statistical analysis capabilities are required before implementing perfused liver assays?
Implementing perfused liver assays requires statistical tools for analyzing metabolic flux, oxygen consumption, and group comparisons. Teams must ensure capability for hypothesis testing, variance analysis, and reproducibility assessment. These analytics are essential for validating assay outputs and supporting portfolio decision-making.
